YML007C-A Antibody

What is YML007C-A and what significance does it hold for yeast research?

YML007C-A refers to a specific open reading frame in the Saccharomyces cerevisiae genome, corresponding to UniProt accession number Q3E7A6 in the reference strain ATCC 204508/S288c. This protein is part of the extensive catalog of yeast proteins studied in molecular and cellular biology research. Understanding this protein's function contributes to our fundamental knowledge of yeast biology, which serves as an important model organism for eukaryotic cellular processes. Antibodies against YML007C-A enable researchers to detect, isolate, and study this protein in various experimental contexts, facilitating investigations into protein expression, localization, and functional relationships within cellular pathways.

What are the key specifications of commercially available YML007C-A Antibody?

The commercially available YML007C-A Antibody (CSB-PA666882XA01SVG) is designed specifically for Saccharomyces cerevisiae (strain ATCC 204508 / S288c). The following table summarizes its key specifications:

This antibody is part of a broader collection of research antibodies targeted at various S. cerevisiae proteins, facilitating detailed proteomic studies in this model organism.

What validation methods should researchers expect for high-quality YML007C-A Antibodies?

Researchers should expect YML007C-A Antibodies to undergo rigorous validation following established principles for antibody validation. According to the International Working Group for Antibody Validation, five key validation pillars should be considered:

• Genetic validation: For YML007C-A, this could involve testing the antibody in wild-type yeast versus strains with YML007C-A gene knockouts or knockdowns to confirm specificity.

• Orthogonal validation: Correlating antibody-based protein detection with RNA expression data or mass spectrometry results.

• Independent antibody validation: Confirming results with multiple antibodies recognizing different epitopes of YML007C-A.

• Expression validation: Demonstrating appropriate signal modulation when YML007C-A is experimentally over-expressed or under-expressed.

• Immunocapture followed by mass spectrometry: Confirming that the antibody captures the intended target.

Researchers should request validation data from suppliers or perform their own validation experiments before using the antibody for critical research applications.

What are the recommended protocols for using YML007C-A Antibody in Western blotting experiments?

When using YML007C-A Antibody for Western blotting in S. cerevisiae research, consider the following methodological approach:

Sample Preparation:

• Extract proteins using glass bead lysis or enzymatic spheroplasting methods optimized for yeast cells

• Include protease inhibitors to prevent degradation of the target protein

• Normalize protein concentration (typically 20-50 μg total protein per lane)

Electrophoresis and Transfer:

• Use 10-15% SDS-PAGE gels depending on the predicted molecular weight of YML007C-A

• Transfer to PVDF or nitrocellulose membranes (0.45 μm pore size recommended)

• Confirm transfer efficiency with Ponceau S staining

Antibody Incubation:

• Block with 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature

• Dilute primary YML007C-A Antibody (1:500 to 1:2000 range, optimize empirically)

• Incubate overnight at 4°C with gentle agitation

• Wash thoroughly with TBST (4-5 times, 5 minutes each)

• Incubate with appropriate HRP-conjugated secondary antibody (1:5000 to 1:10000)

• Perform signal development using chemiluminescence detection

Controls:

• Include positive control (wild-type yeast extract)

• Include negative control (YML007C-A deletion strain if available)

• Include loading control (anti-tubulin or anti-GAPDH antibody)

Signal optimization may require adjusting antibody concentration, incubation time, and washing conditions based on preliminary results.

How can researchers effectively use YML007C-A Antibody for immunoprecipitation studies?

For immunoprecipitation (IP) studies using YML007C-A Antibody in yeast research, follow these methodological guidelines:

Cell Lysis and Extract Preparation:

• Harvest yeast cells during appropriate growth phase

• Lyse cells in non-denaturing IP buffer (typically containing 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40/Triton X-100, 5 mM EDTA, protease inhibitor cocktail)

• Clear lysate by centrifugation (14,000 × g, 10 minutes, 4°C)

Pre-clearing (Optional but Recommended):

• Incubate lysate with Protein A/G beads for 1 hour at 4°C

• Remove beads by centrifugation to reduce non-specific binding

Immunoprecipitation:

• Add 2-5 μg of YML007C-A Antibody to 500-1000 μg of pre-cleared lysate

• Incubate overnight at 4°C with gentle rotation

• Add 30-50 μl of Protein A/G beads, incubate for 2-4 hours at 4°C

• Wash beads 4-5 times with IP buffer

• Elute bound proteins by boiling in SDS sample buffer or using acidic/basic elution

Analysis:

• Analyze immunoprecipitated proteins by Western blot or mass spectrometry

• Confirm successful IP by probing for YML007C-A

• Identify co-immunoprecipitated proteins to discover interaction partners

Controls:

• IgG control (same species as YML007C-A Antibody)

• Input sample (5-10% of lysate used for IP)

• IP from YML007C-A deletion strain (if available)

This approach enables the investigation of protein-protein interactions and protein complexes involving YML007C-A in yeast cells.

What considerations are important when using YML007C-A Antibody for immunofluorescence microscopy?

When performing immunofluorescence microscopy with YML007C-A Antibody in yeast cells, consider these methodological aspects:

Cell Fixation and Permeabilization:

• Fix yeast cells with 3.7% formaldehyde for 30-60 minutes

• Wash cells in PBS buffer

• Create spheroplasts using zymolyase or lyticase treatment (optimize concentration and time)

• Permeabilize with 0.1% Triton X-100 for 5-10 minutes

Blocking and Antibody Incubation:

• Block with 1-3% BSA in PBS for 30-60 minutes

• Dilute YML007C-A Antibody (1:100 to 1:500, optimize empirically)

• Incubate overnight at 4°C in humidity chamber

• Wash thoroughly with PBS (3-4 times, 5 minutes each)

• Incubate with fluorophore-conjugated secondary antibody (1:500 to 1:2000)

• Wash thoroughly with PBS

• Mount slides with anti-fade mounting medium containing DAPI for nuclear counterstaining

Controls and Optimization:

• Include secondary antibody-only control

• Include wild-type and YML007C-A deletion strains if available

• Co-stain with markers for cellular compartments to determine localization

• Optimize fixation and permeabilization conditions for best epitope accessibility

• Use confocal microscopy for improved resolution of subcellular localization

This approach allows visualization of YML007C-A spatial distribution within yeast cells and can provide insights into its functional compartmentalization and dynamics under different experimental conditions.

How can YML007C-A Antibody be validated using genetic approaches specific to yeast research?

Genetic validation of YML007C-A Antibody represents a fundamental approach to ensuring specificity in yeast research. Implement these advanced validation strategies:

Gene Deletion Approach:

• Generate YML007C-A deletion strains using homologous recombination techniques

• Compare antibody reactivity between wild-type and deletion strains via Western blot, immunofluorescence, and other detection methods

• Absence of signal in deletion strains confirms antibody specificity

Epitope Tagging Strategy:

• Create strains expressing YML007C-A with C-terminal or N-terminal epitope tags (HA, FLAG, GFP)

• Perform parallel detection using both YML007C-A Antibody and anti-tag antibodies

• Signal co-localization confirms target specificity

• Differential localization may indicate non-specific binding or epitope masking

Expression Modulation:

• Generate strains with YML007C-A under control of regulatable promoters (GAL1, TET)

• Induce or repress expression and monitor signal intensity changes

• Signal strength should correlate with expression level

Cross-Strain Validation:

• Test antibody reactivity across different yeast strains with known genomic differences

• Compare signal patterns with predicted genetic variations

• Consistent detection indicates robust specificity

These genetic approaches provide definitive validation of antibody specificity and should be documented prior to conducting advanced experiments with YML007C-A Antibody.

What strategies can researchers employ to optimize signal-to-noise ratio when using YML007C-A Antibody?

Optimizing signal-to-noise ratio for YML007C-A Antibody experiments requires methodical troubleshooting and refinement:

Antibody Titration:

• Perform systematic dilution series (1:100 to 1:5000) of YML007C-A Antibody

• Plot signal-to-noise ratio against antibody concentration

• Identify optimal concentration that maximizes specific signal while minimizing background

Buffer Optimization:

• Test multiple blocking agents (BSA, non-fat milk, normal serum, commercial blockers)

• Vary blocking agent concentration (1-5%)

• Adjust detergent type and concentration in wash buffers (Tween-20, Triton X-100)

• Modify salt concentration to reduce non-specific ionic interactions

Sample Preparation Refinement:

• Compare different lysis methods (mechanical, enzymatic, detergent-based)

• Test various extraction buffers with different pH and ionic strength

• Implement pre-clearing steps using protein A/G beads or non-immune IgG

Signal Enhancement Strategies:

• Implement tyramide signal amplification for immunohistochemistry applications

• Use highly sensitive detection substrates for Western blotting

• Employ signal accumulation strategies in microscopy (extended exposure, frame averaging)

Background Reduction:

• Pre-adsorb antibody with yeast lysates from YML007C-A deletion strains

• Include competing proteins (BSA, gelatin) in antibody diluent

• Increase stringency and duration of wash steps

Systematically document all optimization steps and maintain consistent conditions across experimental replicates to ensure reproducible results.

How can researchers address potential cross-reactivity with homologous proteins when using YML007C-A Antibody?

Cross-reactivity with homologous proteins presents a significant challenge when using YML007C-A Antibody. Implement these advanced strategies to address this concern:

Sequence Analysis and Epitope Mapping:

• Perform bioinformatic analysis to identify proteins with sequence similarity to YML007C-A

• Map the epitope recognized by the antibody using peptide arrays or deletion constructs

• Identify potential cross-reactive proteins based on epitope conservation

Knockout Panel Testing:

• Test antibody reactivity in strains with individual knockouts of potential cross-reactive proteins

• Analyze signal patterns to identify contributions from non-target proteins

• Consider using CRISPR-Cas9 to generate multiple knockout strains for comprehensive testing

Immunodepletion Studies:

• Pre-incubate antibody with recombinant homologous proteins

• Compare detection patterns before and after depletion

• Reduction in specific bands/signals indicates cross-reactivity

Mass Spectrometry Validation:

• Perform immunoprecipitation followed by mass spectrometry analysis

• Identify all proteins captured by the antibody

• Quantify relative abundance of target versus non-target proteins

• Calculate specificity metrics based on proteomic data

Competition Assays:

• Perform antibody binding in the presence of increasing concentrations of recombinant YML007C-A

• Monitor signal reduction at potential cross-reactive bands

• Differential competition kinetics can distinguish specific from non-specific binding

These approaches provide a comprehensive assessment of antibody specificity and enable researchers to interpret experimental results with appropriate caution regarding potential cross-reactivity issues.

What are common sources of inconsistent results when using YML007C-A Antibody and how should researchers address them?

Inconsistent results with YML007C-A Antibody can stem from multiple sources requiring systematic troubleshooting:

Antibody Degradation and Storage Issues:

• Store antibody aliquots at -20°C or -80°C to prevent freeze-thaw cycles

• Add preservatives (sodium azide 0.02%) for working dilutions

• Monitor antibody performance with regular quality control testing

• Implement control experiments with each new antibody lot

Sample Preparation Variability:

• Standardize cell growth conditions (media composition, growth phase, temperature)

• Normalize protein concentration using reliable quantification methods

• Optimize lysis conditions to ensure consistent protein extraction

• Document and control post-translational modifications that may affect epitope recognition

Protocol Inconsistencies:

• Develop detailed standard operating procedures (SOPs)

• Control timing of critical steps (antibody incubation, washing, development)

• Maintain consistent reagent quality and preparation methods

• Calibrate equipment regularly (pH meters, balances, pipettes)

Environmental Factors:

• Control temperature during critical experimental steps

• Protect light-sensitive reagents from excessive exposure

• Monitor humidity levels for immunohistochemistry applications

• Implement controlled workflow to minimize variability

Data Analysis Approach:

• Use appropriate statistical methods for analyzing replicate experiments

• Implement normalization procedures to account for loading variations

• Consider blinded analysis to prevent confirmation bias

• Document all anomalies and deviations from expected results

Maintaining a detailed laboratory notebook and implementing rigorous quality control measures are essential for identifying and addressing sources of experimental inconsistency.

How should researchers interpret and validate unexpected banding patterns when using YML007C-A Antibody in Western blots?

Unexpected banding patterns in Western blots using YML007C-A Antibody require systematic investigation and validation:

Pattern Characterization:

• Document molecular weights of all observed bands

• Compare against predicted molecular weight of YML007C-A

• Assess consistency of unexpected bands across experimental replicates

• Determine whether unexpected bands appear in negative controls

Biological Validation:

• Test band patterns in YML007C-A deletion strains (specific bands should disappear)

• Examine band patterns in strains overexpressing YML007C-A (specific bands should intensify)

• Investigate band patterns under conditions that regulate YML007C-A expression

Technical Validation:

• Perform peptide competition assays to identify specific bands

• Use alternative antibodies against YML007C-A (if available) to compare banding patterns

• Apply immunoprecipitation followed by Western blotting to enrich for specific targets

• Consider mass spectrometry analysis of excised bands to identify proteins definitively

Interpretative Framework:

• Higher molecular weight bands: Potential post-translational modifications, aggregation, or cross-reactivity

• Lower molecular weight bands: Potential degradation products, splice variants, or cross-reactivity

• Multiple bands of similar intensity: Potential non-specific binding or cross-reactivity with homologous proteins

Documentation and Reporting:

• Include comprehensive Western blot images in publications (showing full membrane)

• Report all observed bands, not just those of expected size

• Provide detailed methods for band identification and validation

• Indicate potential limitations in antibody specificity

What quantitative approaches can researchers use to analyze YML007C-A expression levels across different experimental conditions?

Quantitative analysis of YML007C-A expression requires rigorous methodological approaches:

Densitometry for Western Blot Quantification:

• Capture high-resolution images using calibrated imaging systems

• Use linear range detection methods (avoid saturated signals)

• Apply appropriate background subtraction methods

• Normalize to loading controls (tubulin, GAPDH, total protein stain)

• Use technical and biological replicates (minimum n=3)

• Apply statistical tests appropriate for data distribution

Flow Cytometry for Single-Cell Analysis:

• Prepare yeast spheroplasts using standardized protocols

• Optimize fixation and permeabilization for intracellular staining

• Establish fluorescence minus one (FMO) controls

• Determine appropriate gating strategy

• Calculate mean fluorescence intensity (MFI) or percent positive cells

• Normalize to reference standards when comparing across experiments

Quantitative Immunofluorescence Microscopy:

• Use identical acquisition settings across all samples

• Include fluorescence intensity calibration standards

• Apply automated image analysis algorithms to reduce bias

• Measure integrated density rather than maximum intensity

• Normalize to cell size or reference proteins

• Analyze sufficient cell numbers for statistical significance (>100 cells)

Relative vs. Absolute Quantification:

• Relative quantification: Compare YML007C-A levels between experimental conditions

• Absolute quantification: Use purified recombinant YML007C-A standards to establish standard curves

• Consider spike-in controls for normalization across complex experiments

Reporting Standards:

• Document all normalization procedures

• Report variability measures (standard deviation, standard error)

• Provide raw data alongside processed results

• Indicate dynamic range of quantification method

• Specify software and algorithms used for analysis

These quantitative approaches enable robust analysis of YML007C-A expression levels and facilitate meaningful comparisons across different experimental conditions and studies.

How can YML007C-A Antibody be utilized in chromatin immunoprecipitation (ChIP) experiments to study protein-DNA interactions?

ChIP experiments using YML007C-A Antibody require specialized protocols adapted for yeast chromatin:

Chromatin Preparation:

• Crosslink yeast cells with 1% formaldehyde for 15-20 minutes

• Quench with glycine (125 mM final concentration)

• Lyse cells using glass bead disruption in appropriate buffer

• Sonicate chromatin to 200-500 bp fragments

• Verify sonication efficiency by agarose gel electrophoresis

Immunoprecipitation Procedure:

• Pre-clear chromatin with protein A/G beads

• Incubate chromatin with YML007C-A Antibody (2-5 μg) overnight at 4°C

• Add protein A/G beads and incubate 2-4 hours

• Perform stringent washing series (low salt, high salt, LiCl, TE buffers)

• Elute DNA-protein complexes and reverse crosslinks

• Purify DNA using column-based methods

Controls and Validation:

• Input chromatin control (non-immunoprecipitated)

• IgG control immunoprecipitation

• Positive control (antibody against known DNA-binding protein)

• Negative control regions (genomic regions not expected to interact)

Data Analysis:

• Perform qPCR for candidate regions or next-generation sequencing

• Normalize to input samples

• Calculate enrichment over IgG control

• Identify significant binding sites using appropriate statistical methods

This approach allows researchers to investigate potential DNA-binding properties or chromatin association of YML007C-A, providing insights into its nuclear functions and regulatory roles.

What considerations are important when designing co-immunoprecipitation experiments to identify YML007C-A interaction partners?

Identifying YML007C-A protein interaction partners requires carefully designed co-immunoprecipitation strategies:

Experimental Design Considerations:

• Choose appropriate lysis conditions to preserve protein-protein interactions

• Consider using reversible crosslinking to capture transient interactions

• Optimize salt concentration to balance specificity and interaction preservation

• Test different detergents (NP-40, Triton X-100, CHAPS) for optimal complex isolation

• Compare native IP versus tag-based approaches if epitope-tagged strains are available

Controls for Interaction Specificity:

• Reciprocal co-IP validation (IP with antibodies against candidate interactors)

• Competition with recombinant YML007C-A protein

• Comparison between wild-type and YML007C-A deletion strains

• Effect of interaction-disrupting mutations or conditions

• Validation across different yeast strains

Detection Methods:

• Western blotting for candidate interactors

• Silver staining followed by mass spectrometry for unbiased discovery

• Proximity labeling approaches (BioID, APEX) for in vivo interaction mapping

• Quantitative proteomics to distinguish specific from non-specific interactions

Interaction Validation:

• Yeast two-hybrid assays for direct interaction testing

• Fluorescence resonance energy transfer (FRET) for in vivo interaction validation

• Bimolecular fluorescence complementation (BiFC) for interaction visualization

• In vitro binding assays with recombinant proteins

This systematic approach enables reliable identification of YML007C-A protein interaction networks, providing insights into its functional roles within cellular pathways.

How can researchers integrate YML007C-A Antibody-based studies with genomic and proteomic approaches for comprehensive functional analysis?

Integration of antibody-based studies with multi-omics approaches provides comprehensive understanding of YML007C-A function:

Integration with Transcriptomics:

• Correlate YML007C-A protein levels with transcript expression profiles

• Identify conditions where post-transcriptional regulation occurs

• Study impact of YML007C-A deletion/overexpression on global gene expression

• Analyze co-expression networks to predict functional relationships

Integration with Proteomics:

• Compare protein abundance (antibody-based) with global proteomic data

• Study post-translational modifications using modification-specific antibodies

• Analyze protein complex composition through affinity purification-mass spectrometry

• Evaluate protein stability and turnover using pulse-chase experiments

Integration with Functional Genomics:

• Correlate antibody-based localization with genome-wide localization studies

• Combine with systematic genetic interaction screens (SGA, E-MAP)

• Integrate with CRISPR-based functional screens

• Analyze phenotypic consequences of YML007C-A perturbation

Data Integration Approaches:

• Implement computational frameworks for multi-omics data integration

• Use network analysis to identify functional modules and pathways

• Apply machine learning algorithms to predict protein function

• Develop visualization tools for integrated data presentation

Validation and Hypothesis Testing:

• Design targeted experiments to test predictions from integrated analyses

• Validate key findings using orthogonal experimental approaches

• Implement perturbation studies to establish causality

• Develop quantitative models to explain observed phenomena

This integrative approach provides a systems-level understanding of YML007C-A function, placing antibody-based findings within broader biological context and generating novel hypotheses for further investigation.